Patricia J. Hare

The AcrAB-TolC Efflux Pump Impacts Persistence and Resistance Development in Stationary-Phase Escherichia coli following Delafloxacin Treatment.

Single-Cell Technologies to Study Phenotypic Heterogeneity and Bacterial Persisters.

Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment.

Resistance-resistant antibacterial treatment strategies.

Metabolic and transcriptional activities underlie stationary-phase sensitivity to Levofloxacin.